TLI Quarterly — September 2024

This edition includes: • REZDIFFRA™ (Resmetirom): A New Hope for Patients with Advanced Fibrosis in Non-Cirrhotic MASH • New Treatment Options for Primary Biliary Cholangitis (PBC): IQIRVO® (elafibranor) and LIVDELZI® (seladelpar) • Hepatocellular Carcinoma in the Non-Cirrhotic Liver • The Liver Spot

Read More

TLI Quarterly — March 2024

This edition contains: • Introducing Andrés Gómez-Aldana, Transplant Hepatologist • Sugar, Sweeteners, and Liver • Cancer: Separating Fact from Fiction • Early Intervent ion Saves Lives: The Crucial Benefit of Early Paracentesis in Hospitalized Cirrhotic Patients Cirrhosis and Nutrition: More Food for Thought • TLI Expansion to Shavano Park Outreach Clinics in Corpus Christi and...

Read More